1. Home
  2. BBW vs OCGN Comparison

BBW vs OCGN Comparison

Compare BBW & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$24.56

Market Cap

473.7M

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.06

Market Cap

474.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
OCGN
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.7M
474.8M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
BBW
OCGN
Price
$24.56
$1.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$67.71
$9.75
AVG Volume (30 Days)
950.5K
6.7M
Earning Date
05-28-2026
05-05-2026
Dividend Yield
2.51%
N/A
EPS Growth
5.00
N/A
EPS
2.16
N/A
Revenue
$357,866,000.00
N/A
Revenue This Year
$5.63
N/A
Revenue Next Year
$4.62
$1,718.38
P/E Ratio
$11.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.43
$0.97
52 Week High
$74.38
$2.73

Technical Indicators

Market Signals
Indicator
BBW
OCGN
Relative Strength Index (RSI) 25.68 35.90
Support Level N/A N/A
Resistance Level $40.16 $1.93
Average True Range (ATR) 1.33 0.08
MACD -0.50 -0.03
Stochastic Oscillator 0.22 20.73

Price Performance

Historical Comparison
BBW
OCGN

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: